Early intravenous β-blocker combined with thrombolytic therapy for acute myocardial infarction: The thrombolysis in myocardial infarction (TIMI-2) trial
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 36 (3), 262-266
- https://doi.org/10.1016/0033-0620(93)90018-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical ExpertsJAMA, 1992
- Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1992
- Adjuncts to Thrombolysis for Myocardial ReperfusionAnnals of Internal Medicine, 1991
- Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.Circulation, 1991
- Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysisJournal of the American College of Cardiology, 1990
- Very early thrombolytic therapy in suspected acute myocardial infarctionThe American Journal of Cardiology, 1990
- Early Intravenous Beta-Blockade in Acute Myocardial InfarctionCardiology, 1989
- The Safety of Combined Thrombolysis and â-Adrenergic Blockade in Patients with Acute Myocardial InfarctionChest, 1988
- Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trialEuropean Heart Journal, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985